Editorial. Achieving optimal outcomes with deep brain stimulation for posttraumatic stress disorder

Staudt, Michael D.; Telkes, Ilknur; Pilitsis, Julie G.

doi:10.3171/2020.5.jns201127

Cited by 1 publication

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After long-term DBS, the CAPS scores were significantly reduced in all three patients, with encouraging follow-up results. Currently, there are 2 ongoing clinical trials of DBS for PTSD: DBS of the amygdala for combat PTSD (NCT02091843) in USA and DBS for treatment refractory PTSD (NCT03416894) in Canada [ 244 ]. Though DBS is a promising treatment for PTSD, its effect and mechanism need to be further studied.…”

Section: Neuromodulationmentioning

confidence: 99%

Post-traumatic stress disorder: a psychiatric disorder requiring urgent attention

Diao

Zhou

et al. 2022

Medical Review

View full text Add to dashboard Cite

Post-traumatic stress disorder (PTSD) is a severe and heterogenous psychiatric disorder that was first defined as a mental disorder in 1980. Currently, the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) and the International Classification of Diseases 11th Edition (ICD-11) offer the most widely accepted diagnostic guidelines for PTSD. In both diagnostic categories, experiencing a traumatic event (TE) is the necessary criterion for diagnosing PTSD. The TEs described in the DSM-5 include actual or threatened death, serious injury, sexual violence, and other extreme stressors, either directly or indirectly. More than 70% of adults worldwide are exposed to a TE at least once in their lifetime, and approximately 10% of individuals develop PTSD after experiencing a TE. The important features of PTSD are intrusion or re-experiencing fear memories, pervasive sense of threat, active avoidance, hyperarousal symptoms, and negative alterations of cognition and mood. Individuals with PTSD have high comorbidities with other psychiatric diseases, including major depressive disorder, generalized anxiety disorder, and substance use disorder. Multiple lines of evidence suggest that the pathophysiology of PTSD is complex, involving abnormal neural circuits, molecular mechanisms, and genetic mechanisms. A combination of both psychotherapy and pharmacotherapy is used to treat PTSD, but has limited efficacy in patients with refractory PTSD. Because of the high prevalence, heavy burden, and limited treatments, PTSD is a psychiatric disorder that requires urgent attention. In this review, we summarize and discuss the diagnosis, prevalence, TEs, pathophysiology, and treatments of PTSD and draw attention to its prevention.

show abstract

Section: Neuromodulationmentioning

confidence: 99%